DIGILAB BIOVISION GMBH has a total of 24 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets measurement, biotechnology and pharmaceuticals are GENOVA LTD, PROTEOME SCIENCES PLC and CRITICAL CARE DIAGNOSTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 4 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Lamping Norbert | 13 |
#2 | Zucht Hans-Dieter | 12 |
#3 | Tammen Harald | 12 |
#4 | Hess Ruediger | 10 |
#5 | Budde Petra | 10 |
#6 | Schorn Karl | 7 |
#7 | Schulz-Knappe Peter | 7 |
#8 | Lamerz Jens | 6 |
#9 | Rose Horst | 6 |
#10 | Neitz Susanne | 4 |
Publication | Filing date | Title |
---|---|---|
US2007037143A1 | Method for screening for protease modulators | |
EP1857818A1 | Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith | |
EP1876448A1 | Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones. | |
EP1795606A1 | Method for screening for proteases and their substrates | |
EP1741790A1 | Methods to identify and characterize prolyl oligopeptidases by using substrates and products thereof | |
EP1742060A1 | TIF1-beta peptides and nucleic acids for diagnosis and therapy of cancer and colorectal cancerous disorders. | |
EP1742059A1 | Use of PTA peptides for stratification of individuals having cancer |